231 related articles for article (PubMed ID: 17328812)
21. Treating mannitol in a saturated solution of mannitol: a novel approach to modify mannitol crystals for improved drug delivery to the lungs.
Kaialy W; Nokhodchi A
Int J Pharm; 2013 May; 448(1):58-70. PubMed ID: 23500603
[TBL] [Abstract][Full Text] [Related]
22. Bioaccessibility studies of ferro-chromium alloy particles for a simulated inhalation scenario: a comparative study with the pure metals and stainless steel.
Midander K; de Frutos A; Hedberg Y; Darrie G; Wallinder IO
Integr Environ Assess Manag; 2010 Jul; 6(3):441-55. PubMed ID: 20821706
[TBL] [Abstract][Full Text] [Related]
23. A rationale for sampling deposited submicrometer beryllium particulate matter.
McCawley M
J Occup Environ Hyg; 2009 Dec; 6(12):789-93. PubMed ID: 19894182
[TBL] [Abstract][Full Text] [Related]
24. Acute pulmonary effects of ultrafine particles in rats and mice.
Oberdörster G; Finkelstein JN; Johnston C; Gelein R; Cox C; Baggs R; Elder AC
Res Rep Health Eff Inst; 2000 Aug; (96):5-74; disc. 75-86. PubMed ID: 11205815
[TBL] [Abstract][Full Text] [Related]
25. Factors affecting the deposition of inhaled porous drug particles.
Musante CJ; Schroeter JD; Rosati JA; Crowder TM; Hickey AJ; Martonen TB
J Pharm Sci; 2002 Jul; 91(7):1590-600. PubMed ID: 12115821
[TBL] [Abstract][Full Text] [Related]
26. Particle characteristics and lung deposition patterns in a human airway replica of a dry powder formulation of polylactic acid produced using supercritical fluid technology.
Cheng YS; Yazzie D; Gao J; Muggli D; Etter J; Rosenthal GJ
J Aerosol Med; 2003; 16(1):65-73. PubMed ID: 12737686
[TBL] [Abstract][Full Text] [Related]
27. Selective detection and characterization of nanoparticles from motor vehicles.
Johnston MV; Klems JP; Zordan CA; Pennington MR; Smith JN;
Res Rep Health Eff Inst; 2013 Feb; (173):3-45. PubMed ID: 23614271
[TBL] [Abstract][Full Text] [Related]
28. Stability and aerodynamic behaviour of glucocorticoid particles prepared by a supercritical fluids process.
Velaga SP; Bergh S; Carlfors J
Eur J Pharm Sci; 2004 Mar; 21(4):501-9. PubMed ID: 14998581
[TBL] [Abstract][Full Text] [Related]
29. Drug transport across pulmonary epithelial cell monolayers: effects of particle size, apical liquid volume, and deposition technique.
Bur M; Huwer H; Muys L; Lehr CM
J Aerosol Med Pulm Drug Deliv; 2010 Jun; 23(3):119-27. PubMed ID: 20073555
[TBL] [Abstract][Full Text] [Related]
30. Size and concentration measurement of an industrial aerosol.
O'Brien D; Baron P; Willeke K
Am Ind Hyg Assoc J; 1986 Jul; 47(7):386-92. PubMed ID: 3751888
[TBL] [Abstract][Full Text] [Related]
31. Investigation of Aerosol Surface Area Estimation from Number and Mass Concentration Measurements: Particle Density Effect.
Ku BK; Evans DE
Aerosol Sci Technol; 2012 Apr; 46(4):473-84. PubMed ID: 26526560
[TBL] [Abstract][Full Text] [Related]
32. Dry powder aerosol delivery systems: current and future research directions.
Chan HK
J Aerosol Med; 2006; 19(1):21-7. PubMed ID: 16551211
[TBL] [Abstract][Full Text] [Related]
33. Development and characterization of a resistance spot welding aerosol generator and inhalation exposure system.
Afshari A; Zeidler-Erdely PC; McKinney W; Chen BT; Jackson M; Schwegler-Berry D; Friend S; Cumpston A; Cumpston JL; Leonard HD; Meighan TG; Frazer DG; Antonini JM
Inhal Toxicol; 2014 Oct; 26(12):708-19. PubMed ID: 25140455
[TBL] [Abstract][Full Text] [Related]
34. Humidity-induced changes of the aerodynamic properties of dry powder aerosol formulations containing different carriers.
Zeng XM; MacRitchie HB; Marriott C; Martin GP
Int J Pharm; 2007 Mar; 333(1-2):45-55. PubMed ID: 17064863
[TBL] [Abstract][Full Text] [Related]
35. Physical and chemical characterization of beryllium particles from several workplaces in Québec, Canada--part A: determining methods for the analysis of low levels of beryllium.
Rouleau M; Dion C; Plamondon P; Kennedy G; L'Espérance G; Zayed J
J Toxicol Environ Health A; 2005 Nov; 68(21):1889-905. PubMed ID: 16207636
[TBL] [Abstract][Full Text] [Related]
36. Tissue distribution of inhaled micro- and nano-sized cerium oxide particles in rats: results from a 28-day exposure study.
Geraets L; Oomen AG; Schroeter JD; Coleman VA; Cassee FR
Toxicol Sci; 2012 Jun; 127(2):463-73. PubMed ID: 22430073
[TBL] [Abstract][Full Text] [Related]
37. Development of a novel dry powder inhalation formulation for the delivery of rivastigmine hydrogen tartrate.
Simon A; Amaro MI; Cabral LM; Healy AM; de Sousa VP
Int J Pharm; 2016 Mar; 501(1-2):124-38. PubMed ID: 26836711
[TBL] [Abstract][Full Text] [Related]
38. Towards the bioequivalence of pressurised metered dose inhalers 1: design and characterisation of aerodynamically equivalent beclomethasone dipropionate inhalers with and without glycerol as a non-volatile excipient.
Lewis DA; Young PM; Buttini F; Church T; Colombo P; Forbes B; Haghi M; Johnson R; O'Shea H; Salama R; Traini D
Eur J Pharm Biopharm; 2014 Jan; 86(1):31-7. PubMed ID: 23523547
[TBL] [Abstract][Full Text] [Related]
39. Particle size-dependent total mass deposition in lungs determines inhalation toxicity of cadmium chloride aerosols in rats. Application of a multiple path dosimetry model.
Cassee FR; Muijser H; Duistermaat E; Freijer JJ; Geerse KB; Marijnissen JC; Arts JH
Arch Toxicol; 2002 Jun; 76(5-6):277-86. PubMed ID: 12107645
[TBL] [Abstract][Full Text] [Related]
40. Simple Method to Measure the Aerodynamic Size Distribution of Porous Particles Generated on Lyophilizate for Dry Powder Inhalation.
Miyamoto K; Taga H; Akita T; Yamashita C
Pharmaceutics; 2020 Oct; 12(10):. PubMed ID: 33076510
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
